Demetrix Secures $50 Million In Series A Funding To Provide Cannabinoids To Pharmaceutical, Supplement, And Consumer Product Companies

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2YUskaw
via IFTTT